FGF19 dynamics in patients with Crohn's colitis and disease controls during the first 6 hours after CDCA ingestion and after 8 days of CDCA ingestion.

Values are in means ± SD; CDCA, chenodeoxycholic acid; FGF19_t0, baseline fasting FGF19 level; FGF19min (ng/mL), minimal FGF19 level in ng/mL; FGF19min (%), minimal FGF19 level as percentage of FGF_t0; ΔFGF19min (ng/mL), difference between FGFmin and FGF_t0; ΔFGF19min (%), percentage difference between FGFmin and FGF_t0; Time FGF19min (hours), time to minimal FGF19 level from t0; FGF19max (ng/mL), maximal FGF19 level; FGF19max (%), maximal FGF19 level as percentage of FGF_t0; ΔFGF19max (ng/mL), difference between FGFmax and FGF_t0; ΔFGF19max (%), percentual difference between FGFmax and FGF_t0; Time FGF19max (hours), time to maximal FGF19 level from t0; AUC (ng/mL*360 min), area under the curve of change of FGF19 level during 360 minutes; AUC (percent*360 min), area under the curve of percentage change of FGF19 level during 360 minutes; FGF19_t8 (ng/mL), FGF19 level after 8 days of CDCA ingestion; FGF19_t8 (%) FGF_t8 as percentage of FGF_t0; ΔFGF19_t8 (ng/mL), difference between FGF19_t8 and FGF19_t0; ΔFGF19_t8 (%), percentage difference between FGF19_t8 and FGF19_t0.